Brief: Lavipharm Signs Asset Purchase Agreement With Boehringer Ingelheim For The Acquisition Of Two Analgesic Pharmaceutical Products

Lavipharm SA

01/12/2023 08:20

Dec 1 (Reuters) - Lavipharm SA  LPHr.AT :
    * SIGNS ASSET PURCHASE AGREEMENT WITH BOEHRINGER INGELHEIM
INTERNATIONAL FOR THE ACQUISITION OF LONARID N AND LONALGAL FOR
THE MARKETS OF GREECE AND CYPRUS
    * THE PRODUCTS ARE EXPECTED TO BE MARKETED BY LAVIPHARM
DURING Q1
2024
    * THE TRANSACTION WILL BE FINANCED BY THE COMPANY’S OWN
FUNDS


Further company coverage:  LPHr.AT 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))